细菌直接养微生物组合对肉牛生长表现,养行为,营养消化能力,反动物形态和尸体特征的影响
Alejandra M Lopez1, Jhones O Sarturi1, Bradley J Johnson1
1Department of Animal and Food Sciences, Texas Tech University, Lubbock, TX 79409, USA.
Journal of animal science
|January 8, 2024
概括
直接养的微生物 (DFM) 改善了养场肉牛的生长和尸体重量. 治疗-A,一个特定的DFM混合物,提高了平均每日增益和增益效率,同时也倾向于增加最终的体重和热尸体重量.
科学领域:
- 动物科学动物科学
- 类动物营养 类动物营养
- 微生物学 微生物学
背景情况:
- 直接养微生物 (DFM) 用于调节肠道微生物群并提高动物的表现.
- 特定的细菌组合和比例可能会对牛生理和生长产生不同的影响.
- 了解DFM对养场牛的影响对于优化生产效率至关重要.
研究的目的:
- 为了评估特定细菌直接养微生物 (DFM) 混合物对料场肉牛生长,尸体特征,营养消化能力,养行为和食者乳头形态的影响.
- 为了比较两个不同的DFM治疗比率 (Treat-A和Treat-B) 与对照组的影响.
主要方法:
- 192只杂交的安格斯牛被分配给一个随机的完整块设计,每次治疗有四个 (控制,治疗A,治疗B) 持续153天.
- 治疗涉及蒸汽片玉米基饮食,不含DFM (控制),治疗-A (特定的DFM混合物在1:1:1:3的比例) 或治疗-B (相同的DFM混合物在1:1:3:1的比例).
- 评估了生长表现,尸体特征,营养消化能力,养行为和牛皮的形态. 数据使用GLIMMIX程序进行分析.
主要成果:
- 与对照群相比,接受Treat-A养的小牛的平均日益增加了6.7% (P=0.03) 和增益效率提高了6% (P<0.01).
- 处理A还倾向于增加体调整后的最终BW (+15公斤,P=0.07) 和热体重量 (+10公斤,P=0.07).
- 与对照组相比,治疗B组在生长,尸体特征或营养消化能力方面没有发现显著差异. 干物质摄入量和大多数尸体特征不受治疗的影响.
结论:
- 在Treat-A中,特定的DFM混合物对料场肉牛的生长性能和屠宰体重产生了积极的影响.
- 治疗-A还显示了改善干物质和纤维消化能力的趋势.
- 经测试的DFM组合似乎没有影响养行为,牛肉形态或牛肉氨度.
相关概念视频
Microbial Growth Measurement: Direct Methods
Direct methods for measuring microbial populations in a culture are essential tools in microbiology, providing quantitative data for various applications. Among these, microscopic counts, plate counts, and serial dilution are widely used techniques, each with unique principles and applications.Microscopic CountsMicroscopic counting involves the use of a Petroff-Hausser chamber, a specialized microscope slide with a grid and defined depth. By observing a liquid culture under a microscope,...
Microbial Growth Measurement: Indirect Methods
Estimating microbial growth is essential for understanding population dynamics and environmental adaptations. Indirect methods provide valuable insights by measuring parameters such as turbidity, metabolic activity, and biomass, enabling efficient and reproducible assessments.During exponential growth, microbial cells scatter light proportionally to their biomass, a principle used in turbidity measurements. About one million cells per milliliter produce detectable scattering, which a...
Biological Methods for Microbial Control
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


